体质量指数对夫精人工授精妊娠结局的影响

doi:10.6040/j.issn.1671-7554.0.2019.973

摘要/Abstract

摘要： 目的探讨不同体质量指数(BMI)患者使用来曲唑联合注射用尿促性素(HMG)诱导排卵宫腔内夫精人工授精(AIH)后妊娠结局的影响。方法对325例接受来曲唑联合HMG诱导排卵宫腔内AIH助孕的不孕患者的临床资料进行回顾性分析,根据BMI 25为分界,将患者分为肥胖组(BMI≥25, n=133)和对照组(BMI<25, n=192),比较患者的年龄、不孕时间、基础性激素水平、窦卵泡数(AFC)、促性腺素(Gn)天数、Gn总量及妊娠结局,评估在诱导排卵周期AIH中BMI与助孕结局的关系。肥胖是多囊卵巢综合征(PCOS)患者的一个重要特征,肥胖组包括PCOS患者68例和非PCOS患者65例,对照组包括PCOS患者83例和非PCOS患者109例,分析PCOS患者对不同BMI引起的助孕结局的影响。结果 (1)肥胖组在诱导排卵AIH周期中Gn的总量和天数均高于对照组(P<0.05); (2)肥胖组生化妊娠率低于对照组(23.3% vs 29.2%, P=0.242),调整泌乳素(PRL)及是否PCOS后,差异仍无统计学意义(OR=0.671,95%CI: 0.399~1.13); (3)肥胖组临床妊娠率低于对照组(17.3% vs 26.6%, P=0.052),调整PRL及是否PCOS后,差异有统计学意义(OR=0.528,95%CI: 0.301~0.928); (4)肥胖组活产率低于对照组(10.5% vs 24.5%, P=0.002),调整PRL及是否PCOS后,差异有统计学意义(OR=0.331,95%CI: 0.172~0.637); (5)肥胖组流产率高于对照组(12.8% vs 4.7%, P=0.011),调整PRL及是否PCOS后,差异有统计学意义(OR=2.82,95%CI: 1.2~6.627)。结论在来曲唑联合HMG诱导排卵宫腔内AIH中,超过正常BMI的肥胖患者比非肥胖患者活产率低。不论是否PCOS患者,异常BMI者均应该通过合理膳食、体育运动、药物治疗等方式降低BMI,可以提高妊娠率。

关键词: 体质量指数, 夫精人工授精, 多囊卵巢综合征, 妊娠结局

Abstract: Objective To explore the impact of body mass index(BMI)on pregnancy outcomes of artificial insemination by husband(AIH)in letrozole plus human menopausal gonadotropin(HMG)ovulation cycle. Methods The clinical data of 325 patients who received AIH with letrozole plus HMG ovulation cycle were retrospectively analyzed. According to BMI, the patients were divided into obese group(BMI≥25 kg/m², n=133)and control group(BMI<25 kg/m², n=192). The clinical baseline parameters and pregnancy outcomes of the two groups were compared, including age, infertility time, basal hormones, antral follicol count(AFC), days and dosage of gonadotropin(Gn), and pregnancy outcomes. In the obese group, 68 patients had polycystic ovary syndrome(PCOS)and 65 had not, while in the control group, 83 had PCOS and 109 had not. The correlation between PCOS and pregnancy outcomes was analyzed. Results The obese group had longer days and higher dosage of Gn than the control group(P<0.05), but lower biochemical pregnancy rate(23.3% vs 29.2%,P=0.242), and there was no significant difference after prolactin(PRL)and PCOS were adjusted(OR=0.671, 95%CI:0.399-1.13). The obese group had lower clinical pregnancy rate than the control group(17.3% vs 26.6%, P=0.052), but there was significant difference after PRL and PCOS were adjusted 山东大学学报 (医学版)58卷1期 -宋海霞,等.体质量指数对夫精人工授精妊娠结局的影响 \=-(OR=0.528, 95%CI:0.301-0.928). The obese group had lower live birth rate than the control group(10.5% vs 24.5%, P=0.002), and there was significant difference after PRL and PCOS were adjusted(OR=0.331, 95%CI:0.172-0.637). The obese group had higher abortion rate than the control group(12.8% vs 4.7%, P=0.011), and there was significant difference after PRL and PCOS were adjusted(OR=2.82, 95%CI:1.2-6.627). Conclusion In AIH with letrozole plus HMG ovulation cycle, obese patients may acquire lower live birth rate than non-obese patients. Obese women with or without PCOS should control BMI by means of diet, sports or drug treatment to improve pregnancy rate.

Key words: Body mass index, Artificial insemination by husband, Polycystic ovary syndrome, Pregnancy outcome

中图分类号:

R711.75

宋海霞,袁彩霞,范玲玲. 体质量指数对夫精人工授精妊娠结局的影响[J]. 山东大学学报 (医学版), 2020, 58(1): 49-53.

SONG Haixia,YUAN Caixia,FAN Lingling. Impact of body mass index on pregnancy outcomes in artificial insemination by husband[J]. Journal of Shandong University (Health Sciences), 2020, 58(1): 49-53.

参考文献

[1] Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome[J]. Nat Genet,2012,44(9): 1020-1025.
[2] AzzizR, CarminaE, Chen Z, et al. Polycystic ovary syndrome[J]. Nat Rev Dis Primers, 2016, 2:16057. doi: 10.1038/nrdp.2016.57.
[3] Pertynska-Marczewska M, Diamanti-Kandarakis E, Zhang J, et al. Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome? [J]. Metabolism, 2015, 64(11): 1564-1573.
[4] Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications[J]. Endocr Rev, 2012, 33(6): 981-1030.
[5] Apovian CM. Obesity:definition, comorbidities, causes, and burden[J]. Am J Manag Care, 2016, 22(7 Suppl): s176-185.
[6] 中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征诊疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6.
[7] Talmor A, Dunphy B. Female obesity and infertility[J]. Best Pract Res Clin Obstet Gynaecol, 2015, 29(4): 498-506.
[8] Christofolini J, Maria Christofolini D, Zaia V. Body fat distribution influences ART outcomes[J].Gynecol Endocrinol, 2019,1630609. doi: 10.1080/09513590. 2019.1630609.
[9] Milone M, De Placido G, Musella M, et al. Incidence of successful pregnancy after weight loss interventions in infertile women: a systematic review and meta-analysis of the literature[J]. Obes Surg, 2016, 26(2): 443-451.
[10] Silvestris E, Lovero D, Palmirotta R. Nutrition and female fertility: an interdependent correlation[J].Front Endocrinol(Lausanne), 2019, 10:346. doi:10.3389/fendo.2019.00346.
[11] Hakimi O, Cameron LC. Effect of Exercise on Ovulation: A Systematic Review[J]. Sports Med, 2017, 47(8): 1555-1567.
[12] Teede H, Deeks A, and Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan[J]. BMC medicine, 2010, 8: 41. doi: 10.1186/1741-7015-8-41.
[13] Bahri Khomami M, Joham AE, Boyle JA, et al.Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-A systematic review, meta-analysis, and meta-regression[J]. Obes Rev, 2019, 20(5): 659-674.
[14] Homburg R, Crawford G. The role of AMH in anovulation associated with PCOS: a hypothesis[J]. Human Reprod, 2014, 29(6): 1117-1121.
[15] 丁楠, 王芳, 简启亮, 等. 不同剂量来曲唑对多囊卵巢综合征患者疗效的Meta分析[J].生殖与避孕, 2015, 35(9): 626-633. DING Nan, WANG Fang, JIAN Qiliang, et al. A meta-analysis of two different dosages of letrozole in women with polycystic ovary syndrome[J]. Reproduction & Contraception, 2015, 35(9): 626-633.
[16] Na L, Chen Y, Zhai H, et al. Effects of maternal body mass index on pregnancy outcome after 8570 artificial insemination cycles with donors sperm[J]. Gynecol Endocrinol, 2018, 34(12): 1068-1072.
[17] Aydin Y, Hassa H, Oge T, et al. Factors predictive of clinical pregnancy in the first intrauterine insemination cycle of 306 couples with favourable female patient characteristics[J]. Hum Fertil(Camb), 2013, 16(4): 286-290.
[18] Joham AE, Palomba S, Hart R. Polycystic ovary syndrome, obesity, and pregnancy[J]. Semin Reprod Med, 2016, 34(2): 93-101.
[19] Vanky E, Engen Hanem LG, Abbott DH. Children born towomen with polycystic ovary syndrome-short-and long-term impacts on health and development[J]. Fertil Steril, 2019, 111(6): 1065-1075.
[20] Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development[J]. Reproduction, 2017, 153(3): R97-R108.
[21] Leeners B, Geary N, Tobler PN, et al. Ovarian hormones and obesity[J]. Hum Reprod Update, 2017, 23(3): 300-321.
[22] Mena GP, Mielke GI, Brown WJ. The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis[J]. Hum Reprod Update, 2019, 25(5): 541-563.

相关文章 15

[1]	吴日超,刘红,王泽,高姗姗,李秀芳,石玉华. 40岁及以上女性行体外受精-胚胎移植助孕的妊娠结局分析[J]. 山东大学学报 (医学版), 2022, 60(6): 35-39.
[2]	虎娜,孙苗,邢莎莎,许丹霞,海小明,马玲,杨丽,勉昱琛,何瑞,陈冬梅,马会明. 月见草油抵抗多囊卵巢综合征大鼠卵巢氧化应激[J]. 山东大学学报 (医学版), 2022, 60(5): 22-30.
[3]	宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[4]	邬晓琳,李萍. 激动剂长方案下促性腺激素使用时长对体外受精胚胎移植妊娠结局的影响[J]. 山东大学学报 (医学版), 2021, 59(7): 32-37.
[5]	郑凤杰,宋玉文,孙爱丽,潘喆,王殿辉,娄能俊,吕丽,庄向华,陈诗鸿. 糖尿病周围神经病变与肌少症的关联性[J]. 山东大学学报 (医学版), 2021, 59(6): 38-44.
[6]	韩笑,李雷,刘聪聪. 睾酮对于多囊卵巢综合征易感基因Tox3表达的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 42-47.
[7]	宫小舒, 吴日超, 李秀芳, 潘烨, 王泽, 石玉华. 603例多囊卵巢综合征患者不同促排卵内膜准备方案对冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 48-54.
[8]	哈灵侠,殷婷,吴阳阳,黎维霞,杜玉冬. 多囊卵巢综合征患者中胰岛素抵抗与子宫内膜局部炎症因子及葡萄糖转运蛋白-4表达的相关性[J]. 山东大学学报 (医学版), 2021, 59(11): 41-47.
[9]	刘晓菲,梁瀛,张丛溪,王娟,潘云,徐嘉蔚,常春,董亮. 92例哮喘患者血清瘦素与诱导痰嗜酸性粒细胞的关系[J]. 山东大学学报 (医学版), 2020, 1(9): 27-33.
[10]	丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60-66.
[11]	贺婷婷,刘红,舒凯云,宋晓翠,石玉华. 多囊卵巢综合征患者颗粒细胞中microRNA-141的表达与意义[J]. 山东大学学报 (医学版), 2019, 57(5): 116-120.
[12]	贺婷婷,刘昕,刘洪彬,赵世刚,张秀清,刘庆庆,游力,石玉华. 多囊卵巢综合征患者颗粒细胞叉头框蛋白O1 mRNA的表达与意义[J]. 山东大学学报 (医学版), 2019, 57(2): 75-79.
[13]	郑庆梅, 姚勤. 复方口服避孕药抑制垂体功能1例分析[J]. 山东大学学报 (医学版), 2019, 57(10): 118-119.
[14]	刘聪聪,刘洪彬,符江,李雷. 多囊卵巢综合征易感基因dennd1a在斑马鱼模型中的表达特性[J]. 山东大学学报 (医学版), 2019, 57(1): 48-54.
[15]	周慧梅,杨佳欣,曹冬焱,沈铿,向阳,吴鸣,潘凌亚,黄惠芳,郎景和. 早期宫颈癌保留生育功能手术的治疗效果及妊娠结局[J]. 山东大学学报 (医学版), 2018, 56(5): 18-22.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed